SCHEMBL31455765

SCHEMBL31455765

COC(=O)c1ccc(C(=O)Nc2ccc(-n3c(-c4cccnc4N)nc4ccc(-c5ccccc5)nc43)cc2F)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 20/20 0.55
AKT2 P31751 16/20 0.55
AKT3 Q9Y243 16/20 0.55
CYP2C9 P11712 5/20 0.49
CYP2C8 P10632 3/20 0.49
CYP2C19 P33261 3/20 0.49
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455776 0.94 AKT1 (0.57) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455934 0.92 AKT1 (0.61) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455637 0.90 AKT1 (0.55) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455699 0.89 AKT1 (0.55) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455820 0.87 AKT1 (0.57) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455074 0.87 AKT1 (0.63) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455741 0.86 AKT1 (0.58) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455647 0.86 AKT1 (0.56) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455792 0.85 AKT1 (0.55) AKT1AKT2AKT3CYP2C9CYP2C8
SCHEMBL31455859 0.84 AKT1 (0.65) AKT1AKT2AKT3CYP2C9CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed